Opinion

Video

Use and Sequencing of Novel Treatments in NMIBC

Experts discuss where they are using FDA-approved treatments for bacille Calmette-Guérin (BCG)–unresponsive patients in their practice, how they choose between these treatments, and how these advances have impacted the timing of radical cystectomy for patients.

Related Videos
1 expert in this video
1 expert in this video
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.